Barclays Downgrades Novartis (NVS) to Underweight
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $157.34 -1.85%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Join SI Premium – FREE
Barclays downgraded Novartis (NYSE: NVS) from Equalweight to Underweight.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $61.66 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $61.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- RBC Capital Downgrades Coty Inc. (COTY) to Sector Perform
- Citi cuts TJX Companies rating to Neutral, lowers price target
Create E-mail Alert Related Categories
DowngradesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
